RxDoctor Payments Data

Aaron Hawkins, MD

Psychiatry · Auburn, ALNPI 1437415163

Payments from drug & device makers

What this record shows

This record is dominated by other: $11,843 of the $15,393 with a category attached, or 76.9%. Neuronetics, Inc. accounts for 78.7% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $11,986, more than ten times the $84 reported in 2019. Among psychiatry clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,393in general payments, 2019–2025

Across 201 payments — averaging $76.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuronetics, Inc.$12K
  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$391
  • Takeda Pharmaceuticals U.S.A., Inc.$322
  • Supernus Pharmaceuticals, Inc.$266
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$230
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,55023%
  • Other$11,84377%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,393 in reported general payments places this provider in the 90th percentile of 400 psychiatry providers in Alabama.

See all psychiatry providers in Alabama

Medicare billing

Part B allowed, 2024
$3,018
Medicare patients
12
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine40$1,030
Alprazolam84$268
Clonazepam34$184
Fluoxetine Hcl11$162
Lorazepam38$138
Buspirone Hcl11$116
Diazepam11$107
Zolpidem Tartrate14$95
Sertraline Hcl16$93
Trazodone Hcl11$20

Paid to pharmacies, not to this prescriber.

Other psychiatry in Auburn

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →